CD28 Emerges as a CAR T Target in T Cell Malignancies
A peer-reviewed Nature Communications study from LMU Munich, the University of Freiburg, and collaborators reports a fratricide-resistant anti-CD28 CAR-T strategy for T-cell acute lymphoblastic leukemia and selected T-cell lymphomas. CRISPR-mediated CD28 knockout enabled manufacture,…
